More on WXXWY
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $7.45 |
|
|||
| Open | $7.91 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $8.18 | ||||
| Day Low | $7.66 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 54,345 | ||||
- WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
- WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
- WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
- WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
- WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities
- WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
- WuXi Biologics Releases 2025 Sustainability Report, Advancing Sustainable Growth and Improving Healthcare Access
- WuXi Biologics Chengdu Microbial Commercial Manufacturing Site Achieves Structural Completion and Key Equipment Arrival
- WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics
- WuXi Biologics Recognized by Morningstar Sustainalytics as Industry and Regional ESG Leader for Sixth Year
Entities mentioned with WXXWY
- FDA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- JPMorgan | View Related Stories »
- IPO | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Twitter | View Related Stories »
- Temasek Holdings | View Related Stories »
- Show More...
